InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Smith Christopher M, 董事长兼首席执行官. Director active across 4 companies, notably Ortho Clinical Diagnostics Holdings plc. Cumulatively, 13 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €1.9m. Activity tracked since 2 August 2021. The latest transaction was filed on 23 February 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Smith Christopher M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
57,413 股0Common StockSEC:0001077183-25-000039:0
54,099 股0Common StockSEC:0001299130-25-000022:0
48,063 股0Common StockSEC:0001077183-24-000168:0
33,130 股0Common StockSEC:0001077183-24-000143:0
48,063 股0Common StockSEC:0001077183-24-000075:0
2,248 股0Common StockSEC:0001209191-23-035401:0
1,225 股@ US$85.54100.0% 占其流量Common StockSEC:0001209191-23-033101:0
336,767 股0Common StockSEC:0001077183-22-000148:0
34,554 股Common StockSEC:0001209191-22-043762:0
34,554 股Common StockSEC:0000899243-22-020478:0
367,360 股Ordinary Shares, $0.00001 par valueSEC:0000899243-22-020381:0
100,000 股@ US$12.5636.5% 占其流量Ordinary Shares, $0.00001 par valueSEC:0001209191-22-001678:0
103,213 股@ US$22.100363.5% 占其流量Ordinary Shares, $0.00001 par valueSEC:0001209191-21-049757:0
13 条申报中的 13 条
About Smith Christopher M
Smith Christopher M is President and Chief Executive Officer. He has 13 filings, and across the 13 sampled filings from 2021-08-04 to 2025-02-25, total sell volume is EUR 1920931, with the dominant transaction nature listed as Attribution. His listed companies are Neogenomics INC, QuidelOrtho Corp, Ortho Clinical Diagnostics Holdings plc, and Pacific Biosciences of California, INC.
